INMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Inmune Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.54−0.03 (-1.91%)
Close on Oct 19, 2026
- Market cap
- $41.15M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
15.7%
4M of 28M shares
Institutional holders
83
24 new, 21 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Xencor, Inc. | 1,885,533 | 9.60% | 13G (passive) amendment | Dec 31, 2023 |
| CVI Investments, Inc. | 1,500,000 | 5.50% | 13G (passive) | Jun 27, 2025 |
| Highbridge Capital Management, LLC | 1,454,400 | 5.20% | 13G (passive) amendment | Jun 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of INMB | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 706,424 | 2.55% | $1.15M | +19,409 | 0.00% |
| Aqr Capital Management LLC | 662,218 | 2.39% | $1.08M | +391,901 | 0.00% |
| BlackRock, Inc. | 311,613 | 1.12% | $507.93K | −882,499 | 0.00% |
| Raymond James Financial Inc | 212,995 | 0.77% | $347.18K | +9,750 | 0.00% |
| Geode Capital Management, LLC | 190,215 | 0.69% | $310.28K | −304,754 | 0.00% |
| Goldman Sachs Group Inc | 185,245 | 0.67% | $301.95K | −46,341 | 0.00% |
| Millennium Management LLC | 159,559 | 0.57% | $260.08K | New | 0.00% |
| Susquehanna International Group, Llp | 158,452 | 0.57% | $258.28K | −35,939 | 0.00% |
| Jane Street Group, LLC | 134,232 | 0.48% | $218.80K | +83,288 | 0.00% |
| UBS Group AG | 110,413 | 0.40% | $179.97K | −142,927 | 0.00% |
| Westside Investment Management, Inc. | 108,300 | 0.39% | $176.54K | – | 0.02% |
| Citadel Advisors LLC | 106,231 | 0.38% | $173.16K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 104,775 | 0.38% | $170.78K | −18,409 | 0.00% |
| State Street Corp | 93,363 | 0.34% | $152.18K | −197,516 | 0.00% |
| Hrt Financial LP | 84,358 | 0.30% | $137 | New | 0.00% |
| Ieq Capital, LLC | 82,385 | 0.30% | $134.29K | +57,822 | 0.00% |
| Gsa Capital Partners Llp | 81,991 | 0.30% | $134 | New | 0.01% |
| Virtu Financial LLC | 75,212 | 0.27% | $123 | New | 0.00% |
| Laird Norton Trust Company, LLC | 52,000 | 0.19% | $84.76K | +2,000 | 0.00% |
| Buckingham Strategic Partners | 43,556 | 0.16% | $71.00K | +531 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 83 | 4M | 15.7% | 24 / 26 | 22 / 21 | 1M | 2M |
| Q1 2026 | 82 | 5M | 19.4% | 18 / 25 | 21 / 9 | 2M | 1M |
| Q4 2025 | 74 | 5M | 18.3% | 12 / 24 | 20 / 10 | 1M | 0M |
| Q3 2025 | 73 | 5M | 17.0% | 16 / 21 | 22 / 22 | 1M | 2M |
| Q2 2025 | 79 | 6M | 20.4% | 19 / 29 | 15 / 22 | 2M | 2M |
| Q1 2025 | 82 | 6M | 22.2% | 18 / 25 | 22 / 8 | 1M | 1M |
| Q4 2024 | 73 | 6M | 22.8% | 15 / 34 | 7 / 8 | 2M | 0M |
| Q3 2024 | 67 | 5M | 19.3% | 19 / 29 | 7 / 7 | 2M | 0M |
| Q2 2024 | 57 | 5M | 16.5% | 19 / 15 | 12 / 14 | 3M | 1M |
| Q1 2024 | 52 | 3M | 10.1% | 11 / 17 | 11 / 7 | 1M | 0M |
| Q4 2023 | 48 | 2M | 8.3% | 14 / 14 | 9 / 3 | 0M | 0M |
| Q3 2023 | 37 | 2M | 7.7% | 7 / 8 | 10 / 4 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of INMB | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 490,268 | 1.77% | $799.14K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 195,995 | 0.71% | $319.47K | 0.00% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 113,711 | 0.41% | $160.33K | 0.00% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 113,297 | 0.41% | $159.75K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 81,590 | 0.29% | $132.99K | 0.01% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 29,204 | 0.11% | $41.18K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 26,591 | 0.10% | $37.49K | 0.00% | May 31, 2026 |
| Vanguard Balanced Index Fund | 20,161 | 0.07% | $32.86K | 0.00% | Jun 30, 2026 |
| Vanguard Russell 2000 Growth Index Fund | 19,552 | 0.07% | $27.57K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 10,829 | 0.04% | $15.27K | 0.00% | May 31, 2026 |
| Small Cap Index Fund | 7,131 | 0.03% | $10.05K | 0.00% | May 31, 2026 |
| 1290 VT Micro Cap Portfolio | 5,575 | 0.02% | $9.09K | 0.00% | Jun 30, 2026 |
| Bridge Builder Small/Mid Cap Growth Fund | 2,925 | 0.01% | $4.77K | 0.00% | Jun 30, 2026 |
| ProShares Russell 2000 High Income ETF | 1,048 | 0.00% | $1.48K | 0.00% | May 31, 2026 |
| ProShares UltraPro Russell2000 | 829 | 0.00% | $1.17K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| David J. Moss | Chief Executive Officer, Director | 1,294,883 | 4.67% | Jul 7, 2026 |
| Raymond Joseph Tesi | President and CEO, Director, 10% owner | 1,554,106 | 5.60% | Dec 9, 2024 |
| Mark William Lowdell | Chief Scientific Officer | 1,518,017 | 5.47% | Jul 7, 2026 |
| Cory Randall Ellspermann | CFO | – | – | Dec 2, 2025 |
| Ronnie Duane Clark | Director | – | – | Sep 23, 2026 |
| James Sapirstein | Director | – | – | Sep 17, 2026 |
| Scott Juda | Director | 158,007 | 0.57% | Jul 7, 2026 |
| Marcia Allen | Director | – | – | Dec 2, 2025 |
| Timothy j. Schroeder | Director | 82,187 | 0.30% | Dec 2, 2025 |
| James Kelly Ganjei | Director | 17,793 | 0.06% | Dec 2, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Mark William Lowdell Chief Scientific Officer | Jul 2, 2026 | Option exercise | +7,211 | $1.40 | $10.10K | 1,518,017 |
| Scott Juda Director | Jul 2, 2026 | Option exercise | +14,801 | $1.40 | $20.72K | 86,404 |
| David J. Moss Chief Executive Officer, Director | Jul 2, 2026 | Option exercise | +9,014 | $1.40 | $12.62K | 1,294,883 |
| David J. Moss Chief Financial Officer, 10% owner | Sep 30, 2024 | Buy | +10,000 | $5.29 | $52.90K | 1,285,869 |
| David J. Moss Chief Financial Officer, 10% owner | Sep 12, 2024 | Buy | +7,690 | $6.38 | $49.06K | 1,275,869 |
| Raymond Joseph Tesi President and CEO, Director, 10% owner | Sep 12, 2024 | Buy | +15,380 | $6.38 | $98.12K | 1,554,106 |
| Scott Juda Director | Jun 25, 2024 | Buy | +5,000 | $7.27 | $36.35K | 71,603 |
| Raymond Joseph Tesi President and CEO, Director, 10% owner | Apr 19, 2024 | Buy | +18,028 | $8.32 | $149.99K | 1,538,726 |
| Scott Juda Director | Apr 19, 2024 | Buy | +29,603 | $8.32 | $246.30K | 66,603 |
| David J. Moss CFO, Treasurer & Secretary, 10% owner | Apr 19, 2024 | Buy | +18,028 | $8.32 | $149.99K | 1,268,179 |
| Mark William Lowdell Chief Scientific Officer, 10% owner | Apr 19, 2024 | Buy | +14,423 | $8.32 | $120.00K | 1,510,806 |
| Mark William Lowdell Chief Scientific Officer, 10% owner | Apr 19, 2024 | Award | +14,423 | $8.32 | $120.00K | 1,510,806 |
| David J. Moss CFO, Treasurer & Secretary, 10% owner | Apr 19, 2024 | Award | +18,028 | $8.32 | $149.99K | 1,268,179 |
| Raymond Joseph Tesi President and CEO, Director, 10% owner | Apr 19, 2024 | Award | +18,028 | $8.32 | $149.99K | 1,538,726 |
| Scott Juda Director | Apr 19, 2024 | Award | +29,603 | $8.32 | $246.30K | 66,603 |
| Scott Juda Director | Nov 10, 2023 | Buy | +7,000 | $6.95 | $48.65K | 37,000 |
| Timothy j. Schroeder Director | Jul 12, 2023 | Sale(10b5-1 plan) | −10,000 | $11.01 | $110.10K | 82,187 |
| David J. Moss CFO, Treasurer & Secretary, 10% owner | Mar 17, 2023 | Buy | +2,500 | $6.43 | $16.08K | 1,250,151 |
| David J. Moss CFO, Treasurer & Secretary, 10% owner | May 27, 2022 | Buy | +3,000 | $6.79 | $20.37K | 1,247,651 |
| David J. Moss CFO, Treasurer & Secretary, 10% owner | May 26, 2022 | Buy | +7,700 | $6.27 | $48.28K | 1,244,651 |
| Raymond Joseph Tesi President and CEO, Director, 10% owner | May 26, 2022 | Buy | +6,300 | $6.41 | $40.38K | 1,520,698 |
| Raymond Joseph Tesi President and CEO, Director, 10% owner | Mar 22, 2022 | Award | +23,724 | $8.43 | $199.99K | 1,514,398 |
| David J. Moss CFO, Treasurer & Secretary, 10% owner | Mar 22, 2022 | Award | +17,793 | $8.43 | $149.99K | 1,236,951 |
| James Kelly Ganjei Director | Mar 22, 2022 | Award | +17,793 | $8.43 | $149.99K | 17,793 |
| Mark William Lowdell Chief Scientific Officer, 10% owner | Mar 22, 2022 | Award | +23,590 | $8.43 | $198.86K | 1,496,383 |
| Scott Juda Director | Nov 17, 2021 | Buy | +2,500 | $13.55 | $33.88K | 30,000 |
| David J. Moss CFO, Treasurer & Secretary, 10% owner | Nov 3, 2021 | Sale(10b5-1 plan) | −1,025 | $20.00 | $20.50K | 1,219,158 |
| Mark William Lowdell Chief Scientific Officer, 10% owner | Nov 3, 2021 | Sale(10b5-1 plan) | −701 | $20.00 | $14.02K | 1,472,793 |
| Raymond Joseph Tesi President and CEO, Director, 10% owner | Nov 3, 2021 | Sale(10b5-1 plan) | −3,626 | $20.00 | $72.52K | 1,490,674 |
| David J. Moss CFO, Treasurer & Secretary, 10% owner | Oct 27, 2021 | Sale(10b5-1 plan) | −2,079 | $20.00 | $41.58K | 1,220,183 |
| Raymond Joseph Tesi President and CEO, Director, 10% owner | Oct 27, 2021 | Sale(10b5-1 plan) | −6,517 | $20.00 | $130.34K | 1,494,300 |
| Mark William Lowdell Chief Scientific Officer, 10% owner | Oct 27, 2021 | Sale(10b5-1 plan) | −2,357 | $20.00 | $47.14K | 1,473,494 |
| David J. Moss CFO, Treasurer & Secretary, 10% owner | Oct 25, 2021 | Sale(10b5-1 plan) | −13 | $20.00 | $260 | 1,222,262 |
| Mark William Lowdell Chief Scientific Officer, 10% owner | Oct 22, 2021 | Sale(10b5-1 plan) | −400 | $20.00 | $8.00K | 1,475,851 |
| Raymond Joseph Tesi President and CEO, Director, 10% owner | Oct 22, 2021 | Sale(10b5-1 plan) | −23,616 | $20.00 | $472.32K | 1,500,817 |
| David J. Moss CFO, Treasurer & Secretary, 10% owner | Oct 22, 2021 | Sale(10b5-1 plan) | −1,142 | $20.00 | $22.84K | 1,222,275 |
| Inc Xencor 10% owner | Sep 3, 2021 | Option exercise | +108,000 | $7.80 | $842.40K | 1,885,533 |
| Raymond Joseph Tesi President and CEO, Director, 10% owner | Aug 25, 2021 | Option exercise | +30,000 | $3.91 | $117.30K | 1,524,433 |
| David J. Moss CFO, Treasurer & Secretary, 10% owner | Jul 16, 2021 | Option exercise | +25,000 | $3.91 | $97.75K | 1,223,417 |
| Timothy j. Schroeder Director | Jul 13, 2021 | Sale(10b5-1 plan) | −14,480 | $27.63 | $400.08K | 92,187 |
| Timothy j. Schroeder Director | Jul 9, 2021 | Sale(10b5-1 plan) | −30,000 | $23.21 | $696.30K | 106,667 |
| Mark William Lowdell Chief Scientific Officer | Jul 8, 2021 | Sale(10b5-1 plan) | −24,150 | $20.19 | $487.59K | 1,476,251 |
| David J. Moss CFO, Treasurer & Secretary | Jul 8, 2021 | Sale(10b5-1 plan) | −16,302 | $20.09 | $327.51K | 1,198,417 |
| Raymond Joseph Tesi President and CEO, Director | Jul 8, 2021 | Sale(10b5-1 plan) | −24,351 | $20.08 | $488.97K | 1,510,933 |
| Mark William Lowdell Chief Scientific Officer | Jul 7, 2021 | Sale(10b5-1 plan) | −5,850 | $20.02 | $117.12K | 1,500,401 |
| David J. Moss CFO, Treasurer & Secretary | Jul 7, 2021 | Sale(10b5-1 plan) | −8,698 | $20.01 | $174.05K | 1,214,719 |
| Raymond Joseph Tesi President and CEO, Director | Jul 7, 2021 | Sale(10b5-1 plan) | −5,649 | $20.02 | $113.09K | 1,535,284 |
| Timothy j. Schroeder Director | Jun 14, 2021 | Sale(10b5-1 plan) | −10,000 | $19.02 | $190.20K | 136,667 |
| Inc Xencor 10% owner | Jun 10, 2021 | Other | +192,533 | $17.14 | $3.30M | 1,777,533 |
| Inc Xencor 10% owner | Jun 10, 2021 | Other | +192,533 | $17.14 | $3.30M | 1,777,533 |
| Inc Xencor 10% owner | Jun 10, 2021 | Other | +192,532 | $17.14 | $3.30M | – |
| Timothy j. Schroeder Director | Jun 10, 2021 | Sale(10b5-1 plan) | −10,000 | $17.01 | $170.10K | 146,667 |
| Timothy j. Schroeder Director | Mar 31, 2021 | Sale | −10,000 | $11.95 | $119.50K | 156,667 |
| Linda F. Powers 10% owner | Jan 27, 2020 | Sale | −220,000 | $4.60 | $1.01M | 210,000 |
| Mark William Lowdell Chief Scientific Officer, 10% owner | Sep 11, 2019 | Buy | +2,918 | $6.23 | $18.18K | 1,506,251 |
| Scott Juda Director | Aug 21, 2019 | Buy | +2,500 | $6.00 | $15.00K | 27,500 |
| Scott Juda Director | Aug 20, 2019 | Buy | +2,500 | $6.00 | $15.00K | 25,000 |
| David J. Moss CFO, Treasurer & Secretary, 10% owner | Aug 20, 2019 | Buy | +376 | $5.65 | $2.12K | 1,223,417 |
| David J. Moss CFO, Treasurer & Secretary, 10% owner | Aug 20, 2019 | Buy | +236 | $5.65 | $1.33K | 1,223,041 |
| David J. Moss CFO, Treasurer & Secretary, 10% owner | Aug 20, 2019 | Buy | +77 | $5.65 | $435 | 1,220,494 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| CTI Holdings, Inc Director | Jul 12, 2023 | 60,000 | $960.09K | Jul 12, 2023 | STOCK PURCHASE |